Report
Michael Waterhouse
EUR 147.86 For Business Accounts Only

BioMerieux Sustains Recent Growth Trajectory

We’re leaving our fair value estimate and narrow economic moat rating for BioMerieux unchanged until we get better visibility on performance when the company reports full first-half results on Aug. 31, 2016. In the meantime, the company’s second-quarter top-line organic growth of 10.3% mostly matched our expectations. Ongoing strength in FilmArray and the recent improvements in the company’s blood culture business sustained impressive growth in the U.S. market, with total North American organic ...
Underlying
BioMerieux SA

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch